JANE STREET GROUP, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$96,000
-74.4%
17,755
-60.4%
0.00%
-100.0%
Q1 2016$375,000
+341.2%
44,820
+316.0%
0.00%
+100.0%
Q4 2015$85,000
-86.2%
10,774
-85.2%
0.00%
-75.0%
Q3 2015$618,000
+39.2%
72,591
+102.2%
0.00%
+33.3%
Q2 2015$444,000
+114.5%
35,895
+105.5%
0.00%
+50.0%
Q1 2015$207,000
-92.7%
17,463
-94.6%
0.00%
-93.1%
Q3 2014$2,829,000
+1489.3%
322,161
+810.3%
0.03%
+1350.0%
Q1 2014$178,00035,3900.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders